India to Tunisia: Rifampicin Export Trade Route

The India to Tunisia Rifampicin corridor is one of India's established pharmaceutical export routes, with 26 shipments documented worth a combined $145.1M USD. The route is dominated by MACLEODS PHARMACEUTICALS LTD, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's rifampicin manufacturing sector.

Across 4 active suppliers, the average shipment value stands at $5.6M USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 72% of all shipments, consistent with rifampicin's non-urgent bulk-order profile.

Shipment activity peaks during October–December, with an average transit time of 34 days port-to-port. The route has recorded an annual growth rate of 29.0%, placing it at rank #7 among India's top rifampicin export destinations globally.

On the import side, key buyers of Indian rifampicin in Tunisia include LA PHARMACIE CENTRALE DE TUNISIE, LA PHARMACIE CENTRALE DE TUNISIE , PHARMACIE CENTRALE DE TUNISIE and 2 others. LA PHARMACIE CENTRALE DE TUNISIE is the single largest importer with 12 shipments valued at $144.8M USD.

India's rifampicin exports to Tunisia are driven primarily by a handful of large-scale manufacturers. MACLEODS PHARMACEUTICALS LTD with 12 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 4 active exporters signals a competitive but concentrated market — buyers in Tunisia benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — MACLEODS PHARMACEUTICALS LTD, MANEESH PHARMACEUTICALS LIMITED , MACLEODS PHARMACEUTICALS LTD — together account for 100% of total trade value on this route. The average shipment value of $5.6M USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as rifampicin 150mg and isoniazid 75mg tablets bno:nrh2366a/nrh2367a md. 07/23 ed.06/26 ps: 24x28s and drugs and pharmaceuticals harmless medicines rifampicin capsules bp 300 mg, suggesting that buyers in Tunisia tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, LA PHARMACIE CENTRALE DE TUNISIE is the largest importer with 12 shipments worth $144.8M USD — representing 100% of all rifampicin imports from India on this route.